American Well Corporation - Class A risk profile
61 Stretched several inputs deteriorating together
Measured 21 October 2026 from AMWL's filed statements. Recomputed nightly.
61 (Stretched), driven by Cash conversion at 100, over 6 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 54 | Elevated | Volatile | One-year price volatility — 71.3% |
| Operating pressure | 1 | Contained | Stable | Input-cost exposure — 0.01 |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.00x |
| Leverage and coverage | 5 | Contained | Stable | Current ratio — 3.37x |
| Competitive position | 83 | Acute | Stable | Operating-margin gap against peers — -30.3 percentage points |
| Concentration | 43 | Elevated | Worsening | Customer concentration — 1,445 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for American Well Corporation - Class A